Jiangxi Wohua Jishun Pharmaceutical Co., Ltd., part of Shandong Wohua Pharmaceutical Co., Ltd., is a Chinese company located in Nanchang that manufactures pharmaceutical products. It was founded in 2000. On June 30, 2015 Shandong Wohua Pharmaceutical Co., Ltd. acquired Jiangxi Wohua Jishun Pharmaceutical Co., Ltd. from Qingdao Zhongzheng Wanrong Medical Technology Co. Ltd. for $19.31 million.

Anhui Jiufang Pharmaceutical Research Institute Co., Ltd., established on 2015-02-05, Business scope includes pharmaceuticals,Healthy food,food,cosmetic,R&D of medical devices,Technology transfer and service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. is engaged in the research, development, processing, wholesale, retail, and manufacturing of Chinese herbal medicines, Chinese patent medicines, Chinese medicine decoction tablets, western medicine preparations, and other medical and health products. It operates through the Chinese Medicine & Western Medicine segments. The Chinese Medicine segment is involved in manufacturing of Chinese pharmaceutical products which are under brands owned by the Group. The Western Medicine segment includes manufacturing of western pharmaceutical products through cooperation with foreign companies. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. It is also involved in the procurement, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services. Its products include Chujoto, L'amour, Tsumura-Kampo Kakkonto, Tsumura-Kampo Otsujito, and Tsumura-Kampo Orengedokuto. The company was founded by Jusha Tsumura on April 10, 1893 and is headquartered in Tokyo, Japan.

Guangzhou Baiyunshan Qi Xing Pharmaceutical Co., Ltd. offers medicine and other pharmaceutical products. It offers medicine in forms of pill, tablet, powder, capsule, granule and oral liquid. The company is headquartered in Guangzhou, China.

Shandong Peptide Biopharmaceutical Co., Ltd., established on 2018-07-16, Business range includes tablet,hard capsule,Granules,small volume injection,Freeze-dried powder injection,API,medical instruments,Cosmetic production,Sales(Except for items restricted and prohibited by national industrial policies);Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval);Biomedical Technology Development,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hefei Runyu Agricultural Technology Co., Ltd., established on 2012-05-07, Business scope includes general items:Agricultural Science Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Soil Pollution Control and Restoration Services;Rural collective economic organization management;Crop Cultivation Services;crop harvesting service;Aquatic planting;Agricultural non-point source and heavy metal pollution prevention and control technical services;Agriculture and Gardening Services;Agricultural production hosting service;Horticultural Products Planting;fruit planting;grain planting;tree planting business;Landscaping engineering construction;Urban Greening Management;Water Environment Pollution Prevention and Control Services;Tourism development project planning consultation;Ecological reserve management services;production of agricultural products,Sales,processing,transportation,Storage and other related services;Aquatic product acquisition;Aquatic product retail;farming,Forest,animal husbandry,vice,Sales of fishery specialized machinery(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Jiangsu Aidea Pharmaceutical Co., Ltd. engages in the production, supply, research and development of UTI raw materials. The company operates through two segments: Formulated Products and Raw Materials. Its products include Folium Sennae Granules, Powdered Bacillus Tablets, Clindamycin Hydrochloride Capsules, Sodium Bicarbonate Tablets, Nitrendipine Tablets, Metronidazole Tablets, Compound Gentamycin Sulfate and Procaine Hydrochloride Sulfate Granules, Cefradine Capsules, Human Urinary Kallidinogenase, Crude Ulinastatin & Urokinase, High Purity Urokinase, Human Serum Albumin, Epidermal Growth Factor, Crude Human Epidermal Growth Factor, Beta-2 Microglobulin and Crude Beta-2 Microglobulin. Jiangsu Aidea Pharmaceutical was founded on December 15, 2009 and is headquartered in Yangzhou, China.

China Medicines and Health Products Co., Ltd., established on 1983-07-18, Business scope includes sales of medical devices(Ikind,IIkind);Processed Chinese Herbal Pieces(branch office only);Professional contractors(Overseas only);Sales of chemical products,car(Passenger cars with less than nine seats are not included),cereals,beans,potatoes,feed,Computer hardware and software and peripheral equipment,communication equipment,Electronic Component,Instrumentation,Machinery and electrical equipment,Agricultural and Livestock Products,cosmetic,hygiene products;Import and export,Technology Import and Export,Agent import and export;Warehousing Services;Leasing instruments and machinery;Leasing of medical equipment and equipment;technology development;technical consulting;Technical Services;Planting Chinese herbal medicines;Acquisition of agricultural and livestock products(Except for projects that have not obtained special permits);Repair medical equipment;Sales of Class III Medical Devices(The medical device business license is valid until2022year11moon13day);Chinese patent medicine,Chemical API,Chemicals,antibiotics,biochemical drug,Biological product,In vitro diagnostic reagents(The drug business license is valid until2024year12moon03day);Prepackaged food sales,Contains refrigerated frozen food;special food sales,limited health food,Infant formula milk powder(The food business license is valid until2025year12moon14day).(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Business items are registered as"production of chemical products";Need to obtain the approval of the environmental protection department first.belonging to business,Business items are registered as"Sales of chemical products".It can also be registered as a"Production of non-pharmaceutical precursor chemicals in the first category"or"Sale of non-pharmaceutical precursor chemicals in category 1"and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Xi'an Jishangji Health Culture Management Co., Ltd., established on 2009-10-30, Business scope includes health records management;Enterprise Marketing Planning,marketing planning;Business Management Consulting,Business Consulting;Conference and Exhibition Services;advertising design,make,acting,release;daily necessities,Health Supplies,food,cosmetic,hygiene products,massager,Sales of physiotherapy instruments and accessories(Including online sales),repair;Goods and technology import and export business;Electronic Component,electronic product,Leasing of machinery and equipment,repair,Sales;Electronic Product Design;computer software development,Sales and technology transfer,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Meikang Chinese Herbal Medicine Co., Ltd., established on 1993-02-08, Business scope includes wholesale of Chinese patent medicines,Chinese Herbal Medicine,Chinese herbal medicine,Chemical API,Chemicals,antibiotics,biochemical drug(The drug business license is valid until2024year12moon3day);Prepackaged food sales,Contains refrigerated frozen food;special food sales,limited health food,Infant formula milk powder(The food business license is valid until2022year09moon14day);Import and export,Technology Import and Export,Agent import and export;Acquisition of native animal products;Planting Chinese herbal medicines;technology development,technical consulting,Technical Services,technology transfer;Economic Information Consulting;Sales of machinery and equipment,Chemical Products(Free of Hazardous Chemicals),cosmetic,medical instruments(limitI,IIkind),farming,Forest,Pasture products,fertilizer;Commissioned processing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jiangyin Tianjiang Pharmaceutical Co., Ltd. produces traditional Chinese medicines. Its product TCM formula particles series made relying on modern science and technology, by simulating traditional decoction method of traditional Chinese medicine decoction as well as by extracting, filtering, concentrating and drying TCM decocting pieces. The company was founded in 1992 and is headquartered in Jiangyin, China.

Sandoz AG, a subsidiary of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Shanghai Shuangke Pharmaceutical Technology Co., Ltd., established on 2008-03-24, The scope of business includes engaging in technology development in the field of medical science and technology;Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)Sales.[Business operations involving administrative licensing,Operating with a license]

Chongqing Fangtong Animal Pharmaceutical Co., Ltd., established on 1999-12-15, Business scope includes licensed projects:Production,Sales:Veterinary preparations(Veterinary biological products,Narcotic Drugs,Except for psychotropic drugs),powder injection,powder/Powder(Contains Chinese herbal extracts)/Premix,tablet(Contains Chinese herbal extracts)/Granules(Contains Chinese herbal extracts),Terminally sterilized small volume injection(Contains Chinese herbal extracts)/Terminally Sterilized Bulk Non-intravenous Injectables(Contains Chinese herbal extracts),Non-terminal sterilized small volume injection/Non-terminal sterilized large volume injection,powder/Premix,Terminally sterilized small volume injection(hormones),Terminally Sterilized Breast Implants(Contains Chinese herbal extracts)/terminally sterilized uterine injection(Contains Chinese herbal extracts),disinfectant(liquid)/insecticide(liquid)/pouring agent/transdermal solution,oral solution(Contains Chinese herbal extracts)/tincture(Contains Chinese herbal extracts)/ointment/cream/ear drops/suppositories.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Foreign trade import and export business.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

China Meheco Co., Ltd. is a state-holding company listed at Shanghai Stock Exchange, (Ticker Symbol: China Meheco; Stock Code: 600056) and its controlling shareholder is China General Technology (Group) Holding Co., Ltd., an important backbone state-owned enterprise directly administered by the central government. Upholding the tenet of "Cherishing Life and Seeking Excellence", China Meheco is dedicated to the promotion of human health and the development of pharmaceutical industry, endeavoring to become a flagship pharmaceutical enterprise in China.